journal article·2020-05-22

β-Cyclodextrin-Self-Assembled Nanochannel Membrane for the Separation of Chiral Drugs

Siyun Zhang, Xue Chen, Lingda Sun, Haibing Li

ACS Applied Nano Materials· Volume 3· Issue 5
Publisher page

Abstract

The fabrication of a membrane with the capability of chiral selective transport is a big challenge in the membrane separation of chiral drugs. To solve the problem of chiral selectivity in membrane separation, drug/metabolite transport (DMT) in the cell membrane inspires a bionic strategy based on the nanochannel membrane. Herein, the DMT-inspired nanochannel membrane is fabricated by the self-assembly of cyclodextrin (CD) in nanochannels and used for the chiral transport and separation of model chiral drugs such as naproxen (NAP). As a result, the β-CD-self-assembled nanochannel membrane shows chiral transport of (S)-naproxen (S-NAP) and achieves the chiral separation of racemic drugs. Moreover, a mechanism of chiral separation is proposed that the chiral selective interaction increases the surface charge density, causing chiral enrichment and transport. Given these promising results, the study of the β-CD-self-assembled nanochannel membrane suggests a bionic strategy for the separation of chiral drugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanopore and Nanochannel Transport Studies · Microfluidic and Capillary Electrophoresis Applications · Membrane-based Ion Separation Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Pesticide and Chemical Biology, Ministry of Education (MOE), College of Chemistry, Central China Normal University (CCNU), Wuhan 430079, P. R. China

Funding

State Administration of Foreign Experts Affairs · Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · Central China Normal University · National Natural Science Foundation of China

References (28)

Show source-provided references
1. 10.1021/ja066422b10.1021/ja066422b ↗
2. 10.1002/1521-3773(20010618)40:12<2356::AID-ANIE2356>3.0.CO;2-S10.1002/1521-3773(20010618)40:12<2356::AID-ANIE2356>3.0.CO;2-S ↗
3. 10.1038/3501501710.1038/35015017 ↗
4. 10.1038/nsmb.323010.1038/nsmb.3230 ↗
5. 10.1038/440427a10.1038/440427a ↗
6. 10.1002/anie.20181092510.1002/anie.201810925 ↗
7. Goulas A. · 2008
8. 10.1021/acsnano.8b0126610.1021/acsnano.8b01266 ↗
9. 10.1046/j.1432-1327.2001.02265.x10.1046/j.1432-1327.2001.02265.x ↗
10. 10.1038/nature1799110.1038/nature17991 ↗
11. 10.1038/4197810.1038/41978 ↗
12. 10.1021/ja063485l10.1021/ja063485l ↗
13. 10.1002/anie.20170125510.1002/anie.201701255 ↗
14. 10.1039/C6NP00006A10.1039/C6NP00006A ↗
15. 10.1038/s41467-017-00330-z10.1038/s41467-017-00330-z ↗
16. 10.1021/ja047171e10.1021/ja047171e ↗
17. 10.1021/ja511713c10.1021/ja511713c ↗
18. 10.1016/j.chemosphere.2005.08.03310.1016/j.chemosphere.2005.08.033 ↗
19. 10.1080/10826076.2011.57115210.1080/10826076.2011.571152 ↗
20. 10.1002/ddr.1033710.1002/ddr.10337 ↗
21. 10.1021/acs.analchem.6b0268210.1021/acs.analchem.6b02682 ↗
22. 10.1021/acs.oprd.6b0002010.1021/acs.oprd.6b00020 ↗
23. 10.1038/s41467-018-05103-w10.1038/s41467-018-05103-w ↗
24. 10.1021/ja909335r10.1021/ja909335r ↗
25. 10.1021/nn500379j10.1021/nn500379j ↗
26. 10.1039/C8NR01191E10.1039/C8NR01191E ↗
27. 10.1038/s41467-019-10381-z10.1038/s41467-019-10381-z ↗
28. 10.1002/anie.20191040810.1002/anie.201910408 ↗